Know Cancer

or
forgot password

Music Video and Adolescent/Young Adult Resilience During Transplant


Phase 3
11 Years
24 Years
Not Enrolling
Both
Cancer

Thank you

Trial Information

Music Video and Adolescent/Young Adult Resilience During Transplant


OBJECTIVES:

- Test the efficacy, in terms of resilience and quality of life, of a therapeutic music
video (TMV) intervention vs listening and discussing books on tape (control group) for
adolescents and young adults (AYA) undergoing autologous or allogeneic transplantation
for cancer.

- Qualitatively describe the perception of helpfulness and meaningfulness of a sub-group
of both interventions for AYA and family members 100 days post-transplant.

OUTLINE: This is a randomized, controlled, limited multicenter study. Patients are
randomized to 1 of 2 arms.

- Arm I (books on tape [control group]): Patients undergo six 1-hour sessions twice a
week for 3 weeks with a trained counselor in which they choose up to 3 books on CD and
listen to the book and/or discuss their impressions and thoughts about the contents
with the counselor. Patients are provided with a portable CD player to listen to the
books during their hospitalization.

- Arm II (therapeutic music video [TMV ] intervention): Patients undergo six 1-hour
sessions twice a week for 3 weeks with a music therapist, designed specifically for the
pre-transplant and acute phase of treatment. Phases of patient participation include
song writing, recording the song with a digital accompaniment track, completing a video
layout worksheet, taking photos or making drawings for the video, viewing clip art and
pictures on a computer, and sharing the final video with family members and hospital
staff.

In both arms, patients complete questionnaires before and after sessions 2, 4, and 6 with
the music therapist. Patients also complete computer-based questionnaires before
hospitalization, after session six during hospitalization, and at 100 days
post-transplantation.

PROJECTED ACCRUAL: A total of 130 patients will be accrued for this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of an oncology condition requiring allogeneic or autologous transplantation

- Receiving or planning to receive a myeloablative treatment regimen and 1 of the
following:

- Marrow transplantation

- Peripheral stem cell transplantation

- Cord blood stem cell transplantation

- Patients with cancers that do not usually occur in childhood/adolescent or young
adult populations (e.g., breast or prostate cancer) are not eligible

PATIENT CHARACTERISTICS:

- Able to read and speak English

- English does not need to be the primary language

- Able to participate in the sessions as evaluated for alertness and engagement by the
music therapist

- No cognitive impairments that would make it difficult to participate in the
intervention or complete questionnaires

- Not married and not a parent

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- Concurrent therapy for pain control or relief of other symptoms allowed

Type of Study:

Interventional

Study Design:

Allocation: Randomized

Outcome Measure:

Symptoms-related distress (pain, anxiety, fatigue, mucositis, sedation, and mood) at pre- and post-sessions 2, 4, and 6, baseline, immediately after completion of study treatment, and 100 days post-transplant

Safety Issue:

No

Principal Investigator

Joan E. Haase, PhD, RN

Investigator Role:

Study Chair

Investigator Affiliation:

Indiana University Melvin and Bren Simon Cancer Center

Authority:

United States: Federal Government

Study ID:

CDR0000463879

NCT ID:

NCT00305851

Start Date:

April 2006

Completion Date:

Related Keywords:

  • Cancer
  • fatigue
  • pain
  • psychosocial effects of cancer and its treatment
  • adult acute myeloid leukemia with 11q23 (MLL) abnormalities
  • adult acute myeloid leukemia with inv(16)(p13;q22)
  • adult acute myeloid leukemia with t(15;17)(q22;q12)
  • adult acute myeloid leukemia with t(16;16)(p13;q22)
  • adult acute myeloid leukemia with t(8;21)(q22;q22)
  • accelerated phase chronic myelogenous leukemia
  • adult acute lymphoblastic leukemia in remission
  • adult acute myeloid leukemia in remission
  • atypical chronic myeloid leukemia, BCR-ABL1 negative
  • blastic phase chronic myelogenous leukemia
  • childhood acute lymphoblastic leukemia in remission
  • childhood acute myeloid leukemia in remission
  • childhood chronic myelogenous leukemia
  • chronic eosinophilic leukemia
  • primary myelofibrosis
  • chronic myelomonocytic leukemia
  • chronic neutrophilic leukemia
  • chronic phase chronic myelogenous leukemia
  • de novo myelodysplastic syndromes
  • disseminated neuroblastoma
  • extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
  • juvenile myelomonocytic leukemia
  • myelodysplastic/myeloproliferative neoplasm, unclassifiable
  • nodal marginal zone B-cell lymphoma
  • noncontiguous stage II adult Burkitt lymphoma
  • noncontiguous stage II adult diffuse large cell lymphoma
  • noncontiguous stage II adult diffuse mixed cell lymphoma
  • noncontiguous stage II adult diffuse small cleaved cell lymphoma
  • noncontiguous stage II adult immunoblastic large cell lymphoma
  • noncontiguous stage II adult lymphoblastic lymphoma
  • noncontiguous stage II grade 1 follicular lymphoma
  • noncontiguous stage II grade 2 follicular lymphoma
  • noncontiguous stage II grade 3 follicular lymphoma
  • noncontiguous stage II mantle cell lymphoma
  • noncontiguous stage II marginal zone lymphoma
  • noncontiguous stage II small lymphocytic lymphoma
  • high risk metastatic gestational trophoblastic tumor
  • previously treated childhood rhabdomyosarcoma
  • previously treated myelodysplastic syndromes
  • recurrent adult acute lymphoblastic leukemia
  • recurrent adult acute myeloid leukemia
  • recurrent adult Burkitt lymphoma
  • recurrent adult Hodgkin lymphoma
  • recurrent adult diffuse large cell lymphoma
  • recurrent adult diffuse mixed cell lymphoma
  • recurrent adult diffuse small cleaved cell lymphoma
  • recurrent adult immunoblastic large cell lymphoma
  • recurrent adult lymphoblastic lymphoma
  • recurrent/refractory childhood Hodgkin lymphoma
  • recurrent childhood acute lymphoblastic leukemia
  • recurrent childhood acute myeloid leukemia
  • recurrent childhood large cell lymphoma
  • recurrent childhood lymphoblastic lymphoma
  • recurrent childhood rhabdomyosarcoma
  • recurrent childhood small noncleaved cell lymphoma
  • recurrent cutaneous T-cell non-Hodgkin lymphoma
  • recurrent grade 1 follicular lymphoma
  • recurrent grade 2 follicular lymphoma
  • recurrent grade 3 follicular lymphoma
  • recurrent mantle cell lymphoma
  • recurrent marginal zone lymphoma
  • recurrent mycosis fungoides/Sezary syndrome
  • recurrent neuroblastoma
  • recurrent ovarian epithelial cancer
  • recurrent ovarian germ cell tumor
  • recurrent small lymphocytic lymphoma
  • recurrent malignant testicular germ cell tumor
  • recurrent Wilms tumor and other childhood kidney tumors
  • refractory chronic lymphocytic leukemia
  • refractory hairy cell leukemia
  • relapsing chronic myelogenous leukemia
  • secondary acute myeloid leukemia
  • secondary myelodysplastic syndromes
  • splenic marginal zone lymphoma
  • stage III adult Burkitt lymphoma
  • stage III adult Hodgkin lymphoma
  • stage III adult diffuse large cell lymphoma
  • stage III adult diffuse mixed cell lymphoma
  • stage III adult diffuse small cleaved cell lymphoma
  • stage III adult immunoblastic large cell lymphoma
  • stage III adult lymphoblastic lymphoma
  • stage III chronic lymphocytic leukemia
  • stage III grade 1 follicular lymphoma
  • stage III grade 2 follicular lymphoma
  • stage III grade 3 follicular lymphoma
  • stage III mantle cell lymphoma
  • stage III marginal zone lymphoma
  • stage III small lymphocytic lymphoma
  • stage III malignant testicular germ cell tumor
  • stage IV adult Burkitt lymphoma
  • stage IV adult Hodgkin lymphoma
  • stage IV adult diffuse large cell lymphoma
  • stage IV adult diffuse mixed cell lymphoma
  • stage IV adult diffuse small cleaved cell lymphoma
  • stage IV adult immunoblastic large cell lymphoma
  • stage IV adult lymphoblastic lymphoma
  • stage IV chronic lymphocytic leukemia
  • stage IV grade 1 follicular lymphoma
  • stage IV grade 2 follicular lymphoma
  • stage IV grade 3 follicular lymphoma
  • stage IV mantle cell lymphoma
  • stage IV marginal zone lymphoma
  • stage IV ovarian epithelial cancer
  • stage IV small lymphocytic lymphoma
  • stage II ovarian epithelial cancer
  • stage III ovarian epithelial cancer
  • childhood myelodysplastic syndromes
  • Ewing sarcoma
  • childhood brain tumor
  • adult brain tumor
  • osteosarcoma
  • Lymphoma, Non-Hodgkin
  • Lymphoma, Large-Cell, Immunoblastic

Name

Location

Methodist Children's Hospital of South Texas San Antonio, Texas  78229-3993
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia  30322
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St. Louis, Missouri  63110